Capella Scientia Development Study

Launched by ALCON RESEARCH · May 16, 2025

Keywords

ClinConnect Summary

The Capella Scientia Development Study is a clinical trial focused on cataracts, which are cloudy areas in the lens of the eye that can affect vision. This study aims to gather important information about eye measurements and how light travels through the eye using a new device called the Unity DX biometer. This research will help improve how cataracts are diagnosed and treated in the future.

To participate in this study, you should be between the ages of 65 and 74, able to understand and sign a consent form, and willing to attend required study visits. Some people may not be eligible, such as those with certain eye conditions or women who could become pregnant. If you join the study, you can expect to have your eye measurements taken with the new device, which could contribute to advancements in cataract care. The study is not yet recruiting participants, so it's a good time to learn more about it if you or a loved one are considering involvement.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Able to understand and sign an IRB/IEC approved consent form;
• • Willing and able to attend study visit(s) as required by the protocol;
• • Consenting age at the jurisdiction of study site;
• • Other group-specific, protocol required inclusion criteria may apply.
• Exclusion Criteria:
• • Women of child-bearing potential;
• • Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus);
• • Unclear optical media preventing data capture from all devices in the study;
• • Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment;
• • Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study;
• • Other group-specific, protocol required exclusion criteria may apply.